Skip to main content
Xspray Pharma logo

Xspray Pharma — Investor Relations & Filings

Ticker · XSPRAY ISIN · SE0023312764 LEI · 549300NGRQCNZ3X4L157 ST Manufacturing
Open in API
Filings indexed 254 across all filing types
Latest filing 2023-05-02 AGM Information
Country SE Sweden
Listing ST XSPRAY

About Xspray Pharma

https://xspraypharma.com/

Xspray Pharma is a pharmaceutical company that utilizes its patented technology platform to develop improved versions of marketed drugs, primarily focusing on Protein Kinase Inhibitors (PKIs) for cancer treatment. The company's core innovation lies in its ability to create stable, amorphous (non-crystalline) formulations of active pharmaceutical ingredients. This unique approach enables the development of product candidates that can bypass the secondary patents of original crystalline drugs, facilitating market entry upon the expiration of the primary substance patent. Xspray Pharma's products are designed to offer clinical benefits for patients compared to the original branded drugs and their subsequent generic equivalents.

Recent filings

Filing Released Lang Actions
Notice of extraordinary general meeting in Xspray Pharma AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "Notice of extraordinary general meeting in Xspray Pharma AB (publ)". It details the date, time, location, registration procedures, agenda items (including resolutions for authorizing share issuance), and voting requirements for an extraordinary general meeting (EGM). This content directly corresponds to the purpose of soliciting shareholder votes and providing necessary pre-meeting information, which aligns with the definition of materials related to a general meeting. Since it is a notice for an EGM, and the options include AGM-R (Annual General Meeting), the most appropriate classification for a general meeting notice is often related to shareholder voting or meeting materials. Given the options, 'AGM-R' (AGM Information) is the closest fit for a general meeting notice, although it is an *extraordinary* meeting. Alternatively, 'PSI' (Proxy Solicitation & Information Statement) is also relevant as it solicits participation and provides information for voting. However, the core purpose is the meeting itself. Since the document is the notice/summons for the meeting, and it contains proposed resolutions, it is fundamentally a meeting document. In the absence of an 'EGM-R' code, 'AGM-R' is the best fit for a general meeting notice, or 'PSI' if focusing on the solicitation aspect. Given the structure and content (summons, agenda, proposed resolutions), it functions as the primary notice for the meeting. I will select AGM-R as the primary meeting type indicator.
2023-05-02 English
Kallelse till extra bolagsstämma i Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till extra bolagsstämma i Xspray Pharma AB (publ)" which translates to 'Notice of Extraordinary General Meeting in Xspray Pharma AB (publ)'. It details the date, time, location, registration procedures, agenda items (including proposals for authorizing the board to issue new shares/options), and voting requirements for an upcoming shareholder meeting. This content directly corresponds to the definition of materials shared for a General Meeting, specifically an Extraordinary General Meeting (EGM). The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM), and by extension, EGMs. Although it is a 'Notice' (Kallelse), which sometimes suggests RPA, the document contains the full context, agenda, and proposals, making it substantive meeting material rather than just a brief announcement of publication. Therefore, AGM-R is the most appropriate classification.
2023-05-02 Swedish
Xspray announces a rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "Xspray announces a rights issue of units of approximately SEK 300 million ahead of Dasynoc product launch." It details the terms of a rights issue, including subscription prices, warrants, dilution effects, and commitments from existing shareholders. A rights issue is a specific type of capital raising or financing activity. This directly corresponds to the definition of 'Capital/Financing Update' (CAP). Although it mentions a prospectus will be published later, the core content is the announcement and details of the financing event itself, not just the announcement of the report (which would be RPA/RNS).
2023-05-02 English
Xspray offentliggör en företrädesemission av units om cirka 300 MSEK inför Dasynocs produktlansering
Capital/Financing Update Classification · 98% confidence The document is a press release from Xspray Pharma AB dated May 2, 2023, announcing a rights issue ('företrädesemission') of approximately 300 MSEK, involving new shares and warrants (TO5 and TO6). It details the terms, purpose (financing Dasynoc launch), shareholder voting requirements (Extra Bolagsstämman), subscription periods, and existing commitments/guarantees. This clearly falls under the category of financing activities and capital structure changes. It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is a specific announcement about raising capital through a rights issue, which aligns best with the 'Capital/Financing Update' definition (Code: CAP). Although it mentions a prospectus will be published later (suggesting RPA), the core content is the financing deal itself, making CAP the primary classification.
2023-05-02 Swedish
Notice of annual general meeting of Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document explicitly begins with the title "Notice of annual general meeting of Xspray Pharma AB (publ)". It details the date, time, location, registration procedures, and the proposed agenda for the meeting. The agenda items cover the election of the chairman, board members, auditors, remuneration, and resolutions on incentive programs, which are all standard components of an AGM notice. This directly corresponds to the definition of AGM Information (AGM-R). Although it is a notice, the content is the core material for the meeting itself, making AGM-R the most precise classification over a general RPA or RNS.
2023-04-13 English
Kallelse till årsstämma i Xspray Pharma AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Xspray Pharma AB (publ)" which translates to "Notice of Annual General Meeting in Xspray Pharma AB (publ)". It details the date, time, location, registration procedures, and the proposed agenda for the meeting. The agenda items (e.g., election of chairman, approval of remuneration guidelines, decisions on incentive programs) are characteristic of materials distributed ahead of an Annual General Meeting (AGM) to inform shareholders and solicit votes. This directly corresponds to the definition of AGM materials, which is classified as AGM-R.
2023-04-13 Swedish

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.